Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations
Status:
Terminated
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Transtec(R) PRO 70 µg/h and a new
buprenorphine patch formulation lead to same plasma levels of buprenorphine after multiple
dose application.